NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $63.24 +0.84 (+1.35 %) (As of 11/16/2018 04:00 PM ET)Previous Close$63.24Today's Range$62.29 - $63.7452-Week Range$57.41 - $77.91Volume5.34 million shsAverage Volume6.59 million shsMarket Capitalization$54.18 billionP/E Ratio22.03Dividend Yield2.69%Beta0.75 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York. Receive CL News and Ratings via Email Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Toilet preparations Sub-IndustryHousehold Products SectorConsumer Staples Current SymbolNYSE:CL Previous Symbol CUSIP19416210 Webwww.colgate.comen-usenusoc Phone212-310-2000 Debt Debt-to-Equity Ratio64.85 Current Ratio1.11 Quick Ratio0.77 Price-To-Earnings Trailing P/E Ratio22.03 Forward P/E Ratio21.36 P/E Growth3.07 Sales & Book Value Annual Sales$15.45 billion Price / Sales3.55 Cash Flow$3.4824 per share Price / Cash18.16 Book Value($0.08) per share Price / Book-790.50 Profitability EPS (Most Recent Fiscal Year)$2.87 Net Income$2.02 billion Net Margins13.55% Return on Equity12,004.60% Return on Assets20.46% Miscellaneous Employees35,900 Outstanding Shares867,320,000Market Cap$54.18 billion OptionableOptionable Colgate-Palmolive (NYSE:CL) Frequently Asked Questions What is Colgate-Palmolive's stock symbol? Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL." How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive? Colgate-Palmolive announced a quarterly dividend on Thursday, September 13th. Stockholders of record on Friday, October 19th will be paid a dividend of $0.42 per share on Thursday, November 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date is Thursday, October 18th. View Colgate-Palmolive's Dividend History. How will Colgate-Palmolive's stock buyback program work? Colgate-Palmolive declared that its board has initiated a stock repurchase plan on Monday, June 18th 2018, which authorizes the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 9% of its shares through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued. How were Colgate-Palmolive's earnings last quarter? Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday, October, 26th. The company reported $0.72 EPS for the quarter, hitting the consensus estimate of $0.72. The company had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The company's revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.73 EPS. View Colgate-Palmolive's Earnings History. When is Colgate-Palmolive's next earnings date? Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January 25th 2019. View Earnings Estimates for Colgate-Palmolive. How can I listen to Colgate-Palmolive's earnings call? Colgate-Palmolive will be holding an earnings conference call on Friday, January 25th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link. What price target have analysts set for CL? 17 brokers have issued 12 month target prices for Colgate-Palmolive's shares. Their forecasts range from $54.00 to $79.00. On average, they expect Colgate-Palmolive's stock price to reach $67.0667 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive. What is the consensus analysts' recommendation for Colgate-Palmolive? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 3 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive. What are Wall Street analysts saying about Colgate-Palmolive stock? Here are some recent quotes from research analysts about Colgate-Palmolive stock: 1. According to Zacks Investment Research, "Colgate lagged the industry in the past three months due to its dismal sales trend. Notably, sales missed estimates in 21 of the last 22 quarters, including third-quarter 2018. Also, sales dipped year over year due to currency headwinds, trade inventory reductions in China and volatility in Brazil. It continues to anticipate a challenging backdrop due to uncertain global markets and slowing category growth worldwide. Consequently, it expects sales to decline low-single digits in the fourth quarter. Additionally, the company continues to witness strained gross and operating margins trend for the last few quarters, which is likely to persist in 2018. However, the company’s earnings retained its meet or beat track record as bottom line were in line with estimates in the third quarter. Further, the company provided a favorable earnings view for 2018. It also remains optimistic about brand building and productivity maximization initiatives." (10/29/2018) 2. Wells Fargo & Co analysts commented, "We maintain our FY18/FY19 EPS estimates by $3.02/$3.27 and our $64 price target." (7/27/2018) 3. Jefferies Financial Group Inc analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018) Has Colgate-Palmolive been receiving favorable news coverage? News headlines about CL stock have trended somewhat positive on Saturday, InfoTrie reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. Who are some of Colgate-Palmolive's key competitors? Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), Coty (COTY), HYPERA S A/S (HYPMY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Revlon (REV), Mandom (MDOMF), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM). Who are Colgate-Palmolive's key executives? Colgate-Palmolive's management team includes the folowing people: Mr. Ian M. Cook, Chairman & CEO (Age 65)Mr. Noel R. Wallace, Pres & COO (Age 54)Mr. Dennis J. Hickey, Vice Chairman (Age 70)Mr. Franck J. Moison, Vice Chairman (Age 64)Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 58) Who are Colgate-Palmolive's major shareholders? Colgate-Palmolive's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.16%), Massachusetts Financial Services Co. MA (3.63%), Bank of New York Mellon Corp (2.35%), Loomis Sayles & Co. L P (1.29%), FMR LLC (0.81%) and OppenheimerFunds Inc. (0.78%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive. Which major investors are selling Colgate-Palmolive stock? CL stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Alecta Pensionsforsakring Omsesidigt, Mitsubishi UFJ Trust & Banking Corp, Massachusetts Financial Services Co. MA, TIAA CREF Investment Management LLC, FMR LLC, Schroder Investment Management Group and Findlay Park Partners LLP. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive. Which major investors are buying Colgate-Palmolive stock? CL stock was bought by a variety of institutional investors in the last quarter, including Genesis Asset Managers LLP, Hexavest Inc., Mondrian Investment Partners LTD, AQR Capital Management LLC, Manning & Napier Group LLC, Swedbank, AXA and Oakbrook Investments LLC. View Insider Buying and Selling for Colgate-Palmolive. How do I buy shares of Colgate-Palmolive? Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Colgate-Palmolive's stock price today? One share of CL stock can currently be purchased for approximately $63.24. How big of a company is Colgate-Palmolive? Colgate-Palmolive has a market capitalization of $54.18 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe. What is Colgate-Palmolive's official website? The official website for Colgate-Palmolive is http://www.colgate.com/en-us/en/us/oc. How can I contact Colgate-Palmolive? Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected] MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)Community Ranking: 1.6 out of 5 ()Outperform Votes: 358 (Vote Outperform)Underperform Votes: 752 (Vote Underperform)Total Votes: 1,110MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/17/2018 by MarketBeat.com StaffFeatured Article: What is the NASDAQ Stock Market?